All lobbying filings

BRIDGEBIO PHARMA, INC.

Lobbying for BRIDGEBIO PHARMA, INC. · Biotech company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $270,000.00 expenses · posted Jan 20, 2026

Official filing document

Bills named in this filing 2

HR 1262
Mikaela Naylon Give Kids a Chance Act
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 1

Pharmacy

Give Kids a Chance Act of 2025 - H.R. 1262; S 932 General issues and provisions related to PBM Reform ORPHAN Cures Act - included in H.R. 1 - One Big Beautiful Bill Act Orphan drug policies

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.